BioLife Solutions - 股票

BioLife Solutions 负债 2024

BioLife Solutions 负债

-8.72 USD

股票代码

BLFS

ISIN

US09062W2044

WKN

A1XCF2

在2024年,BioLife Solutions的债务为-8.72 USD,与前一年6.5 USD的总债务相比变动了-234.12%

BioLife Solutions Aktienanalyse

BioLife Solutions在做什么?

BioLife Solutions Inc. was founded in 1998 and has since been continuously working on the development and production of bioproducts. The company is based in Bothell, Washington and employs over 50 staff members. BioLife Solutions specializes in the development of biological storage and transportation solutions, offering innovative products and services to companies in the biotechnology, cell therapy, and regenerative medicine sectors. The business model of BioLife Solutions is based on the sale of cryopreservation media and devices for packaging and storing biological materials. The company offers a wide range of products and services, including bioproducts, cryopreservation media, cell transport containers, and automatic freezers. These products allow companies in the biotechnology, cell therapy, and regenerative medicine industries to safely and effectively transport and store their products, contributing to increased product quality. BioLife Solutions works with leading biotechnology companies, cell therapy centers, and scientific institutions. The company has a strong network in the industry and is able to offer customized solutions to meet specific customer requirements. BioLife Solutions prides itself on not only providing biological products and devices to its customers but also offering expert advice and support in product selection and service. BioLife Solutions offers various divisions, such as cryopreservation media, cell transport containers, and automatic freezers. The cryopreservation media are typically mixed with cells before being frozen and stored. The special media ensure that the cells maintain their biological properties during storage and can be reactivated when needed. BioLife Solutions' cell transport containers are designed to safely transport cells without damage. These containers are available in different sizes and shapes and ensure the safe transport of cells and tissues worldwide. BioLife Solutions' automatic freezers are equipped with an intelligent system that automates the storage and management of biological materials. The products are designed to meet specific customer requirements and contribute to increased product quality. In terms of products, BioLife Solutions offers a wide range of innovative solutions. One of its most well-known products is CryoStor, a cryopreservation media frequently used in cell storage and transport. CryoStor allows companies to store and transport their cells safely and effectively. BioLife Solutions has also developed an automatic cell storage device called SmartStore, which is capable of automatically storing and monitoring biological materials. SmartStore provides an intelligent and user-friendly solution for the automatic storage of biological materials and contributes to improved product quality. BioLife Solutions' mission is to offer innovative biological products and solutions that contribute to improved product quality and simplified biological research and therapy. The company continues to strive for the development of products that meet specific customer requirements and help improve the biotechnology industry. BioLife Solutions ist eines der beliebtesten Unternehmen auf Eulerpool.com.

负债的详细信息

BioLife Solutions的债务结构理解

BioLife Solutions的总债务是指该公司欠外部各方的累积金融义务。这可能包括短期和长期贷款、债券、贷款和其他金融工具。评估公司的债务对于评估其财务状况,风险概况以及运营和扩展业务的能力至关重要。

年对年对比

通过对BioLife Solutions多年债务结构的分析,可以洞察公司的财务策略和稳定性。债务的减少可能暗示了财务实力和运营效率,而债务的增加可能表明投资增长或潜在的财务挑战。

对投资的影响

投资者会密切关注BioLife Solutions的债务,因为这会影响公司的风险和收益概况。过度的债务可能导致财务压力,而适度并且管理良好的债务可能是增长和扩张的催化剂。这使得债务成为投资评估的重要一环。

债务波动的解读

BioLife Solutions债务水平的变化可能归因为各种运营和策略因素。债务的增加可能旨在资助扩张项目或提高运营能力,而债务的减少可能意味着利润的实现或是一种减小财务风险和杠杆效应的方法。

关于BioLife Solutions股票的常见问题

BioLife Solutions今年的债务有多高?

BioLife Solutions今年的债务水平为-8.72 USD。

BioLife Solutions的债务与去年相比有多高?

BioLife Solutions的债务与去年相比增长了-234.12% 下降了

BioLife Solutions的投资者高额债务会有什么后果?

对于BioLife Solutions的投资者来说,高额债务可能构成风险,因为它会使公司的财务状况变得较弱,可能会影响其履行义务的能力。

BioLife Solutions的投资者低债务会有什么后果?

低债务意味着BioLife Solutions拥有强大的财务地位,并且能够履行其义务,而不会导致其财务负担过重。

BioLife Solutions的债务增加对公司会有什么影响?

BioLife Solutions的债务增加可能会影响公司的财务状况,从而导致其财务负担增加。

BioLife Solutions的债务减少会对公司产生什么影响?

将BioLife Solutions的债务降低可以增强公司的财务状况并提高其履行财务义务的能力。

BioLife Solutions的债务受哪些因素影响?

影响BioLife Solutions负债的一些因素可能包括投资、收购、运营成本和营业收入的发展。

为什么BioLife Solutions的债务对投资者如此重要?

BioLife Solutions的债务对投资者来说很重要,因为它是公司财务稳定性的指标,并且能向投资者提供有关公司如何履行其财务义务的信息。

BioLife Solutions可以采取哪些战略措施来改变债务状况?

为了改变债务状况,BioLife Solutions可以采取包括削减成本、增加收入、出售资产、接受投资或合作伙伴关系等措施。公司必须对其财务状况进行彻底审查,以确定最佳的战略措施来改变其债务状况。

BioLife Solutions支付多少股息?

在过去的12个月中,BioLife Solutions支付了 的股息。这相当于大约的股息收益率。在未来的12个月内,BioLife Solutions预计将支付0 USD的股息。

BioLife Solutions的股息收益率有多高?

BioLife Solutions当前的股息收益率为。

BioLife Solutions什么时候支付股息?

BioLife Solutions按季度支付股息。这些股息将在月份分发。

BioLife Solutions的股息有多安全?

BioLife Solutions 在过去0年里每年都支付了股息。

BioLife Solutions的股息有多高?

预计未来12个月的股息将达到0 USD。这相当于0 %的股息收益率。

BioLife Solutions位于哪个行业?

BioLife Solutions 被分配到“健康”板块。

Wann musste ich die Aktien von BioLife Solutions kaufen, um die vorherige Dividende zu erhalten?

要获得BioLife Solutions在支付的0 USD的最后一笔股息,你必须在的除息日之前持有该股票于你的账户中。

BioLife Solutions最后一次支付股息是什么时候?

上一次股息发放日期为。

BioLife Solutions在2023年的股息是多少?

在2023年,BioLife Solutions 分配了0 USD作为股息。

BioLife Solutions 的股息是以哪种货币支付的?

BioLife Solutions的股息将以USD的形式分配。

股票储蓄计划为投资者提供了一种吸引人的方法,可以长期累积财富。主要优势之一是所谓的成本平均效应:通过定期投入固定金额于股票或股票基金,当价格低时自动买入更多份额,价格高时买入较少,这可能随着时间带来更优惠的平均每份成本。此外,股票储蓄计划还允许小额投资者接触到高价股票,因为他们可以用很小的金额参与其中。定期投资也促进了一种纪律投资策略,并有助于避免情绪化的决策,如冲动买卖。除此之外,投资者还能从股票的潜在增值以及可以再投资的股息分红中获益,这增强了复利效应,从而增加了投资资本的增长。

BioLife Solutions 股票在以下供应商处可进行定投计划:Trade Republic

Andere Kennzahlen von BioLife Solutions

我们对BioLife Solutions 营业额股票的股票分析包括重要的财务指标,如收入、利润、市盈率、市销率、息税折旧摊销前利润,以及有关股息的信息。此外,我们还研究了诸如股票、市值、债务、股东权益和BioLife Solutions 营业额的负债等方面。如果您在寻找关于这些主题的更详细信息,我们在子页面上提供了详细的分析: